Insider Buying: Ultralife Co. (NASDAQ:ULBI) Director Buys $19,775.00 in Stock

Ultralife Co. (NASDAQ:ULBIGet Free Report) Director W. Shaw Robert purchased 2,500 shares of Ultralife stock in a transaction dated Tuesday, November 12th. The stock was bought at an average cost of $7.91 per share, with a total value of $19,775.00. Following the completion of the transaction, the director now owns 65,250 shares in the company, valued at approximately $516,127.50. This represents a 3.98 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

Ultralife Trading Down 1.0 %

NASDAQ ULBI opened at $7.67 on Friday. The firm has a market cap of $127.55 million, a PE ratio of 13.95 and a beta of 0.98. Ultralife Co. has a 52 week low of $6.36 and a 52 week high of $13.39. The company has a quick ratio of 2.06, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The company has a 50 day moving average price of $9.01 and a 200 day moving average price of $10.28.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Get Our Latest Analysis on ULBI

Institutional Trading of Ultralife

Hedge funds and other institutional investors have recently made changes to their positions in the business. Quadrature Capital Ltd acquired a new position in Ultralife during the 1st quarter valued at approximately $200,000. Empowered Funds LLC increased its position in shares of Ultralife by 7.8% in the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after acquiring an additional 2,275 shares during the period. O Shaughnessy Asset Management LLC purchased a new position in Ultralife in the 1st quarter worth $100,000. Hillsdale Investment Management Inc. acquired a new stake in Ultralife during the 1st quarter worth about $166,000. Finally, Vanguard Group Inc. lifted its position in Ultralife by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after acquiring an additional 6,640 shares during the period. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.